biomerieux uk limited

biomerieux uk limited Company Information

Share BIOMERIEUX UK LIMITED
Live 
MatureLargeHealthy

Company Number

01061914

Industry

Other manufacturing n.e.c.

 

Shareholders

biomerieux sa

Group Structure

View All

Contact

Registered Address

chineham gate, 1st floor, crockford lane, basingstoke, RG24 8NA

biomerieux uk limited Estimated Valuation

£136.3m

Pomanda estimates the enterprise value of BIOMERIEUX UK LIMITED at £136.3m based on a Turnover of £89m and 1.53x industry multiple (adjusted for size and gross margin).

biomerieux uk limited Estimated Valuation

£72.3m

Pomanda estimates the enterprise value of BIOMERIEUX UK LIMITED at £72.3m based on an EBITDA of £6.9m and a 10.55x industry multiple (adjusted for size and gross margin).

biomerieux uk limited Estimated Valuation

£29.3m

Pomanda estimates the enterprise value of BIOMERIEUX UK LIMITED at £29.3m based on Net Assets of £14m and 2.09x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Biomerieux Uk Limited Overview

Biomerieux Uk Limited is a live company located in basingstoke, RG24 8NA with a Companies House number of 01061914. It operates in the other manufacturing n.e.c. sector, SIC Code 32990. Founded in July 1972, it's largest shareholder is biomerieux sa with a 100% stake. Biomerieux Uk Limited is a mature, large sized company, Pomanda has estimated its turnover at £89m with healthy growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Biomerieux Uk Limited Health Check

Pomanda's financial health check has awarded Biomerieux Uk Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 6 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating3out of 5
positive_score

4 Strong

positive_score

2 Regular

positive_score

6 Weak

size

Size

annual sales of £89m, make it larger than the average company (£14.2m)

£89m - Biomerieux Uk Limited

£14.2m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 7%, show it is growing at a similar rate (6.3%)

7% - Biomerieux Uk Limited

6.3% - Industry AVG

production

Production

with a gross margin of 30.3%, this company has a comparable cost of product (30.2%)

30.3% - Biomerieux Uk Limited

30.2% - Industry AVG

profitability

Profitability

an operating margin of 4.4% make it less profitable than the average company (6.4%)

4.4% - Biomerieux Uk Limited

6.4% - Industry AVG

employees

Employees

with 128 employees, this is above the industry average (70)

128 - Biomerieux Uk Limited

70 - Industry AVG

paystructure

Pay Structure

on an average salary of £91.8k, the company has a higher pay structure (£42.6k)

£91.8k - Biomerieux Uk Limited

£42.6k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £695.3k, this is more efficient (£185.8k)

£695.3k - Biomerieux Uk Limited

£185.8k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 64 days, this is later than average (53 days)

64 days - Biomerieux Uk Limited

53 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 9 days, this is quicker than average (40 days)

9 days - Biomerieux Uk Limited

40 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 40 days, this is less than average (68 days)

40 days - Biomerieux Uk Limited

68 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 1 weeks, this is less cash available to meet short term requirements (12 weeks)

1 weeks - Biomerieux Uk Limited

12 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 68.1%, this is a higher level of debt than the average (47.6%)

68.1% - Biomerieux Uk Limited

47.6% - Industry AVG

BIOMERIEUX UK LIMITED financials

EXPORTms excel logo

Biomerieux Uk Limited's latest turnover from December 2023 is £89 million and the company has net assets of £14 million. According to their latest financial statements, Biomerieux Uk Limited has 128 employees and maintains cash reserves of £823.4 thousand as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Turnover88,999,96677,304,98585,095,07371,869,73257,827,80855,975,55754,448,59252,008,81748,968,88347,055,38744,577,47942,311,20939,009,01134,734,62337,171,729
Other Income Or Grants000000000000000
Cost Of Sales62,030,75551,743,84961,581,85346,929,20735,015,78234,257,55936,383,22833,422,11733,106,75632,189,44328,707,23827,875,40726,349,14723,581,79624,041,420
Gross Profit26,969,21125,561,13623,513,22024,940,52522,812,02621,717,99818,065,36418,586,70015,862,12714,865,94415,870,24114,435,80212,659,86411,152,82713,130,309
Admin Expenses23,064,25820,975,62917,099,28320,624,65117,030,72216,218,09816,430,20614,576,01113,853,36013,834,41513,113,81412,783,44611,350,72610,753,06710,344,404
Operating Profit3,904,9534,585,5076,413,9374,315,8745,781,3045,499,9001,635,1584,010,6892,008,7671,031,5292,756,4271,652,3561,309,138399,7602,785,905
Interest Payable61,83449,02333510,43115,1076413,32610,85014,7162,0143,10121,08028,74692,16460,200
Interest Receivable96,42133,4832,1394,77818,06520,6796,55710,9155,1896,7344,2209426,43455,72372,072
Pre-Tax Profit3,905,6484,531,1896,374,4196,038,1035,738,9996,216,8371,579,1573,954,2361,942,6641,066,1532,722,9461,659,4181,268,426363,3192,797,777
Tax-920,509-886,367-1,206,938-1,121,867-1,111,781-1,140,619-300,507-818,676-422,682-260,965-706,040-463,946-403,720-169,429-831,675
Profit After Tax2,985,1393,644,8225,167,4814,916,2364,627,2185,076,2181,278,6503,135,5601,519,982805,1882,016,9061,195,472864,706193,8901,966,102
Dividends Paid3,480,0002,580,0007,200,00007,200,0001,900,000950,000353,0002,400,0001,280,0000500,000860,00003,000,000
Retained Profit-494,8611,064,822-2,032,5194,916,236-2,572,7823,176,218328,6502,782,560-880,018-474,8122,016,906695,4724,706193,890-1,033,898
Employee Costs11,744,8649,636,4478,999,5908,491,8237,587,2857,129,2036,781,8896,630,3246,073,7037,228,3846,373,8335,615,7155,561,6114,974,0704,641,893
Number Of Employees12811011311711610710810598107106106949694
EBITDA*6,855,8487,358,7879,164,8696,853,4038,161,9007,199,6134,046,1306,153,6784,115,5682,933,4574,467,2563,237,9312,858,8081,948,5404,132,300

* Earnings Before Interest, Tax, Depreciation and Amortisation

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Tangible Assets12,117,47012,141,29512,440,7229,109,7809,878,4078,066,5905,653,9826,022,1854,271,8024,583,3385,006,9325,221,5504,437,8093,754,0902,908,806
Intangible Assets726,902739,233791,878877,083960,1621,148,7841,297,7051,273,8961,324,6111,445,989714,981810,312905,6421,000,9731,096,304
Investments & Other00001,624,5081,624,5081,624,5081,624,5081,624,5081,624,5081,624,5081,624,5081,624,5081,624,5081,624,508
Debtors (Due After 1 year)000000000000000
Total Fixed Assets12,844,37212,880,52813,232,6009,986,86312,463,07710,839,8828,576,1958,920,5897,220,9217,653,8357,346,4217,656,3706,967,9596,379,5715,629,618
Stock & work in progress6,937,9535,397,3177,701,6318,349,4735,442,8894,966,0025,312,7424,585,8514,944,7764,696,8754,492,2584,011,9444,268,9103,799,7212,732,181
Trade Debtors15,738,17717,848,44116,097,27511,838,99710,672,5237,529,5098,204,9668,453,6086,527,3437,201,9556,464,3245,346,8245,489,8444,668,9544,727,585
Group Debtors6,500,4695,135,2902,304,0377,564,938538,2416,059,8841,929,0281,215,9331,577,8031,004,2061,458,259213,111186,078147,483850,643
Misc Debtors1,164,5321,114,9281,624,058933,802716,454723,6081,194,632906,543818,291747,249607,503612,878677,524688,600565,435
Cash823,437615,943586,1011,086,664636,4511,073,121782,045721,90366,75399,33270,67599,120299,383611,206220,399
misc current assets000000000000000
total current assets31,164,56830,111,91928,313,10229,773,87418,006,55820,352,12417,423,41315,883,83813,934,96613,749,61713,093,01910,283,87710,921,7399,915,9649,096,243
total assets44,008,94042,992,44741,545,70239,760,73730,469,63531,192,00625,999,60824,804,42721,155,88721,403,45220,439,44017,940,24717,889,69816,295,53514,725,861
Bank overdraft00000000000040,09873,4000
Bank loan000000000000000
Trade Creditors 1,626,4702,248,445827,132562,361907,5381,425,864640,2581,501,847678,465834,089549,376729,254876,768389,417283,226
Group/Directors Accounts16,596,27614,952,52014,972,41112,620,84910,576,0869,550,5199,027,8146,733,7237,658,2167,221,5835,273,5865,658,6087,000,5696,384,3044,276,371
other short term finances000000000000000
hp & lease commitments381,869326,530274,300560,535591,7230000000000
other current liabilities9,986,1849,582,19210,171,7067,985,1985,537,8175,264,8824,714,5805,418,2434,632,4774,330,2194,076,9072,797,8922,266,6901,781,4472,691,239
total current liabilities28,590,79927,109,68726,245,54921,728,94317,613,16416,241,26514,382,65213,653,81312,969,15812,385,8919,899,8699,185,75410,184,1258,628,5687,250,836
loans00000000001,843,6201,843,6201,843,6201,843,6201,843,620
hp & lease commitments688,328494,300615,555153,210606,6050000000000
Accruals and Deferred Income000000000000000
other liabilities000000000000000
provisions66,252282,13447,9961,245,726717,623931,478680,880664,098649,963643,655125,410383,86135,10914,93537,323
total long term liabilities1,377,0601,485,1403,360,0464,186,8723,570,8232,555,7392,922,2052,757,8532,137,2642,132,5553,086,4062,989,2422,391,8042,271,7352,360,247
total liabilities29,967,85928,594,82729,605,59525,915,81521,183,98718,797,00417,304,85716,411,66615,106,42214,518,44612,986,27512,174,99612,575,92910,900,3039,611,083
net assets14,041,08114,397,62011,940,10713,844,9229,285,64812,395,0028,694,7518,392,7616,049,4656,885,0067,453,1655,765,2515,313,7695,395,2325,114,778
total shareholders funds14,041,08114,397,62011,940,10713,844,9229,285,64812,395,0028,694,7518,392,7616,049,4656,885,0067,453,1655,765,2515,313,7695,395,2325,114,778
Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Operating Activities
Operating Profit3,904,9534,585,5076,413,9374,315,8745,781,3045,499,9001,635,1584,010,6892,008,7671,031,5292,756,4271,652,3561,309,138399,7602,785,905
Depreciation2,938,5642,720,6352,665,7272,435,6282,174,7541,495,4692,234,1461,980,8161,948,9291,806,5971,615,4981,490,2441,454,3391,453,4491,251,064
Amortisation12,33152,64585,205101,901205,842204,244176,826162,173157,87295,33195,33195,33195,33195,33195,331
Tax-920,509-886,367-1,206,938-1,121,867-1,111,781-1,140,619-300,507-818,676-422,682-260,965-706,040-463,946-403,720-169,429-831,675
Stock1,540,636-2,304,314-647,8422,906,584476,887-346,740726,891-358,925247,901204,617480,314-256,966469,1891,067,5402,732,181
Debtors-695,4814,073,289-312,3678,410,519-2,385,7832,984,375752,5421,652,647-29,973423,3242,357,273-180,633848,409-638,6266,143,663
Creditors-621,9751,421,313264,771-345,177-518,326785,606-861,589823,382-155,624284,713-179,878-147,514487,351106,191283,226
Accruals and Deferred Income403,992-589,5142,186,5082,447,381272,935550,302-703,663785,766302,258253,3121,279,015531,202485,243-909,7922,691,239
Deferred Taxes & Provisions-215,882234,138-1,197,730528,103-213,855250,59816,78214,1356,308518,245-258,451348,75220,174-22,38837,323
Cash flow from operations4,656,3195,769,38210,171,689-2,955,2608,499,7695,007,865717,7205,664,5633,627,9003,100,8211,764,3153,944,0242,130,258524,208-2,563,431
Investing Activities
capital expenditure-2,914,739-2,421,208-5,996,669-1,685,823-4,003,791-3,963,400-2,066,578-3,842,657-1,673,887-2,209,342-1,400,880-2,273,986-2,138,058-2,298,733-5,351,505
Change in Investments000-1,624,50800000000001,624,508
cash flow from investments-2,914,739-2,421,208-5,996,669-61,315-4,003,791-3,963,400-2,066,578-3,842,657-1,673,887-2,209,342-1,400,880-2,273,986-2,138,058-2,298,733-6,976,013
Financing Activities
Bank loans000000000000000
Group/Directors Accounts1,643,756-19,8912,351,5622,044,7631,025,567522,7052,294,091-924,493436,6331,947,997-385,022-1,341,961616,2652,107,9334,276,371
Other Short Term Loans 000000000000000
Long term loans000000000-1,843,62000001,843,620
Hire Purchase and Lease Commitments249,367-69,025176,110-484,5831,198,3280000000000
other long term liabilities000000000000000
share issue138,3221,392,691127,704-356,962-536,572524,033-26,660-439,26444,477-93,347-328,992-243,990-86,16986,5646,148,676
interest34,587-15,5401,804-5,6532,95820,0383,23165-9,5274,7201,119-20,138-22,312-36,44111,872
cash flow from financing2,066,0321,288,2352,657,1801,197,5651,690,2811,066,7762,270,662-1,363,692471,58315,750-712,895-1,606,089507,7842,158,05612,280,539
cash and cash equivalents
cash207,49429,842-500,563450,213-436,670291,07660,142655,150-32,57928,657-28,445-200,263-311,823390,807220,399
overdraft00000000000-40,098-33,30273,4000
change in cash207,49429,842-500,563450,213-436,670291,07660,142655,150-32,57928,657-28,445-160,165-278,521317,407220,399

biomerieux uk limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for biomerieux uk limited. Get real-time insights into biomerieux uk limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Biomerieux Uk Limited Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for biomerieux uk limited by selecting its closest rivals, whether from the MANUFACTURING sector, other large companies, companies in RG24 area or any other competitors across 12 key performance metrics.

biomerieux uk limited Ownership

BIOMERIEUX UK LIMITED group structure

Biomerieux Uk Limited has 3 subsidiary companies.

Ultimate parent company

INSTITUT MERIEUX

#0071062

BIOMERIEUX SA

#0013012

2 parents

BIOMERIEUX UK LIMITED

01061914

3 subsidiaries

BIOMERIEUX UK LIMITED Shareholders

biomerieux sa 100%

biomerieux uk limited directors

Biomerieux Uk Limited currently has 3 directors. The longest serving directors include Mr Ivan Chemarin (Aug 2011) and Mr Paul Skingley (Jul 2022).

officercountryagestartendrole
Mr Ivan ChemarinEngland57 years Aug 2011- Director
Mr Paul SkingleyEngland51 years Jul 2022- Director
Mr Bertrand PlayeEngland53 years Apr 2024- Director

P&L

December 2023

turnover

89m

+15%

operating profit

3.9m

-15%

gross margin

30.4%

-8.36%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2023

net assets

14m

-0.02%

total assets

44m

+0.02%

cash

823.4k

+0.34%

net assets

Total assets minus all liabilities

biomerieux uk limited company details

company number

01061914

Type

Private limited with Share Capital

industry

32990 - Other manufacturing n.e.c.

incorporation date

July 1972

age

52

incorporated

UK

ultimate parent company

INSTITUT MERIEUX

accounts

Full Accounts

last accounts submitted

December 2023

previous names

api biomerieux (uk) limited (October 1990)

api laboratory products limited (September 1987)

accountant

-

auditor

GRANT THORNTON UK LLP

address

chineham gate, 1st floor, crockford lane, basingstoke, RG24 8NA

Bank

HSBC BANK PLC

Legal Advisor

PENNINGTONS MANCHES COOPER LLP

biomerieux uk limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to biomerieux uk limited.

biomerieux uk limited Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for BIOMERIEUX UK LIMITED. This can take several minutes, an email will notify you when this has completed.

biomerieux uk limited Companies House Filings - See Documents

datedescriptionview/download